Viewing Study NCT07037004


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2025-12-25 @ 7:08 PM
Study NCT ID: NCT07037004
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-23
First Post: 2025-06-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module